{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:26:29Z","timestamp":1790724389862,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sao Paulo Research Foundation (FAPESP)","award":["2022\/02339-4"],"award-info":[{"award-number":["2022\/02339-4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Colchicine is an alkaloid traditionally used to treat inflammatory conditions such as gout and familial Mediterranean fever. Currently, there are proposals for the use of this drug in several other situations, such as cardiovascular and liver diseases and diabetes. In this study, the current literature on the potential of colchicine in the treatment of obesity and metabolic syndrome (MS) was evaluated. The inhibitory action of the NLRP3 inflammasome and other processes, such as reductions in the migration and activation of immune system cells, are effects observed in both in vitro studies and animal models related to colchicine, as well as the promotion of mechanisms of the intensification of lipid metabolism, the reduction of tissue fibrosis, and the reduction of serum glucose and triglycerides. These factors are associated with changes in the prognoses of patients with MS, which, together with obesity, has a high association with inflammatory mechanisms for its maintenance and secondary impairments to homeostasis. In humans, clinical research has rarely addressed the use of colchicine in obesity and MS, with only one pilot randomized clinical trial having been conducted, which identified a beneficial anti-inflammatory effect on endothelial function and the process of insulin resistance in this population. However, it is not yet possible to extrapolate its findings and apply its results to a broader context. Given the potential of this \u201cancient drug\u201d in various pathological contexts and its good tolerability, it is important that its properties continue to be investigated and that more clinical studies be conducted to expand the therapeutic applications of this low-cost substance in patients with obesity and MS.<\/jats:p>","DOI":"10.3390\/metabo14110629","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T10:44:37Z","timestamp":1732013077000},"page":"629","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Action of Colchicine in Patients with Metabolic Syndrome and Obesity: Perspectives and Challenges"],"prefix":"10.3390","volume":"14","author":[{"given":"F\u00e1bio Vieira de","family":"Bulh\u00f5es","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2953-5323","authenticated-orcid":false,"given":"Gabriele Eliza","family":"Assis","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-8801","authenticated-orcid":false,"given":"Ana Beatriz","family":"Caz\u00e9","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-2813","authenticated-orcid":false,"given":"Jackson Pedro","family":"Barros-Pereira","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7396-647X","authenticated-orcid":false,"given":"Gabriela Garcia de Carvalho","family":"Laguna","sequence":"additional","affiliation":[{"name":"Multidisciplinary Institute of Health, Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-1188","authenticated-orcid":false,"given":"Alex Cleber","family":"Improta-Caria","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology of the Exercise, Physical Education and Sport School, University of Sao Paulo (USP), Sao Paulo 05508-030, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque","family":"Aras-J\u00fanior","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Federal University of Bahia (UFBA), Salvador 40110-060, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: An Ancient Drug with Novel Applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5694\/mja14.00846","article-title":"Colchicine\u2014A Short History of an Ancient Drug","volume":"201","author":"Nerlekar","year":"2014","journal-title":"Med. J. Aust."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1517\/17425255.2015.1076391","article-title":"Colchicine as an Anti-Inflammatory and Cardioprotective Agent","volume":"11","author":"Gasparyan","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kurek, J., Myszkowski, K., Okulicz-Kozaryn, I., Kurant, A., Kami\u0144ska, E., Szulc, M., Rubi\u015b, B., Kaczmarek, M., Miko\u0142ajczak, P.\u0141., and Murias, M. (2021). Cytotoxic, Analgesic and Anti-Inflammatory Activity of Colchicine and Its C-10 Sulfur Containing Derivatives. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-88260-1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.36011\/cpp.2022.4.e5","article-title":"Anti-Inflammatory Effects of Colchicine on Coronary Artery Disease","volume":"4","author":"Park","year":"2022","journal-title":"Cardiovasc. Prev. Pharmacother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/kei140","article-title":"Mechanism of the Anti-Inflammatory Effect of Colchicine in Rheumatic Diseases: A Possible New Outlook through Microarray Analysis","volume":"45","author":"Bergmann","year":"2006","journal-title":"Rheumatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109924","DOI":"10.1016\/j.diabres.2022.109924","article-title":"Geographic Distribution of Metabolic Syndrome and Its Components in the General Adult Population: A Meta-Analysis of Global Data from 28 Million Individuals","volume":"188","author":"Noubiap","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, W., Qiu, X., Ma, H., and Geng, Q. (2023). Incidence and Long-Term Specific Mortality Trends of Metabolic Syndrome in the United States. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1029736"},{"key":"ref_10","unstructured":"Swarup, S., and Zeltser, R. (2024, August 04). Metabolic Syndrome. Nih.gov, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459248\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.numecd.2021.10.014","article-title":"Lifetime Risk of Cardiovascular Disease and Life Expectancy with and without Cardiovascular Disease According to Changes in Metabolic Syndrome Status","volume":"32","author":"Li","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The Global Burden of Metabolic Disease: Data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/jc.2004-0165","article-title":"Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?","volume":"89","author":"Karelis","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ferrari, C.K.B. (2024). Epidemiology of Metabolic Syndrome: Global Scenario. Metabolic Syndrome, Elsevier.","DOI":"10.1016\/B978-0-323-85732-1.00038-4"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and Inflammation: The Linking Mechanism and the Complications","volume":"4","author":"Ellulu","year":"2017","journal-title":"Aoms"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014Update on Mechanisms of Action and Therapeutic Uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine Pharmacokinetics and Mechanism of Action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1024\/0301-1526\/a001104","article-title":"Inflammation, Anti-Inflammatory Agents, and the Role of Colchicine in Carotid Artery Stenosis","volume":"53","author":"Chlorogiannis","year":"2024","journal-title":"Vasa"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine Poisoning: The Dark Side of an Ancient Drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2016.04.039","article-title":"Colchicine to Decrease NLRP3-Activated Inflammation and Improve Obesity-Related Metabolic Dysregulation","volume":"92","author":"Demidowich","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jacl.2019.10.011","article-title":"Colchicine\u2019s Effects on Lipoprotein Particle Concentrations in Adults with Metabolic Syndrome: A Secondary Analysis of a Randomized Controlled Trial","volume":"13","author":"Demidowich","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1161\/hh0701.090462","article-title":"Microtubule Disruption by Colchicine Reversibly Enhances Calcium Signaling in Intact Rat Cardiac Myocytes","volume":"88","author":"Kerfant","year":"2001","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hawash, M. (2022). Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy. Biomolecules, 12.","DOI":"10.3390\/biom12121843"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40001-024-01836-1","article-title":"The Effect of Colchicine on Cancer Risk in Patients with Immune-Mediated Inflammatory Diseases: A Time-Dependent Study Based on the Taiwan\u2019s National Health Insurance Research Database","volume":"29","author":"Yeh","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e018993","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine Alters the Quantitative and Qualitative Display of Selectins on Endothelial Cells and Neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10753-023-01956-6","article-title":"Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway","volume":"47","author":"Yuan","year":"2024","journal-title":"Inflammation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s42255-024-01079-8","article-title":"Obesity-Induced Inflammation: Connecting the Periphery to the Brain","volume":"6","year":"2024","journal-title":"Nat. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41418-022-01062-4","article-title":"Cell Death and Inflammation during Obesity: \u201cKnow My Methods, WAT(Son)\u201d","volume":"30","author":"Hildebrandt","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic Inflammation and Insulin Resistance in Obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ. Res."},{"key":"ref_31","first-page":"e22711","article-title":"Obesity: A Chronic Low-Grade Inflammation and Its Markers","volume":"14","author":"Khanna","year":"2022","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, Adipose Tissue and Vascular Dysfunction","volume":"128","author":"Koenen","year":"2021","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Savulescu-Fiedler, I., Mihalcea, R., Dragosloveanu, S., Scheau, C., Baz, R.O., Caruntu, A., Scheau, A.-E., Caruntu, C., and Benea, S.N. (2024). The Interplay between Obesity and Inflammation. Life, 14.","DOI":"10.3390\/life14070856"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.pharmtox.45.120403.095843","article-title":"FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity","volume":"45","author":"Lafontan","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/mmr.2024.13219","article-title":"Molecular and Pathophysiological Relationship between Obesity and Chronic Inflammation in the Manifestation of Metabolic Dysfunctions and Their Inflammation-mediating Treatment Options (Review)","volume":"29","author":"Varra","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"ref_36","first-page":"678159","article-title":"Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation","volume":"2013","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111677","DOI":"10.1016\/j.mce.2022.111677","article-title":"Colchicine Stimulates Browning via Antagonism of GABA Receptor B and Agonism of \u03923-Adrenergic Receptor in 3T3-L1 White Adipocytes","volume":"552","author":"Choi","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2022.03.114","article-title":"Colchicine Prevents Ventricular Arrhythmias Vulnerability in Diet-Induced Obesity Rats","volume":"610","author":"Lv","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12944-017-0573-8","article-title":"Per Os Colchicine Administration in Cholesterol Fed Rabbits: Triglycerides Lowering Effects without Affecting Atherosclerosis Progress","volume":"16","author":"Kaminiotis","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/dom.13702","article-title":"Effects of Colchicine in Adults with Metabolic Syndrome: A Pilot Randomized Controlled Trial","volume":"21","author":"Demidowich","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/oby.23632","article-title":"Immunomodulatory Effects of Colchicine on Peripheral Blood Mononuclear Cell Subpopulations in Human Obesity: Data from a Randomized Controlled Trial","volume":"31","author":"Patel","year":"2023","journal-title":"Obesity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.12938\/bmfh.2023-001","article-title":"Colchicine Effects on the Gut Microbiome in Adults with Metabolic Syndrome","volume":"42","author":"Kisimba","year":"2023","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/oby.23341","article-title":"Effects of Colchicine on Lipolysis and Adipose Tissue Inflammation in Adults with Obesity and Metabolic Syndrome","volume":"30","author":"Levine","year":"2022","journal-title":"Obesity"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"CHI Consortium, Demidowich, A.P., Levine, J.A., Apps, R., Cheung, F.K., Chen, J., Fantoni, G., Patel, T.P., and Yanovski, J.A. (2020). Colchicine\u2019s Effects on Metabolic and Inflammatory Molecules in Adults with Obesity and Metabolic Syndrome: Results from a Pilot Randomized Controlled Trial. Int. J. Obes., 44, 1793\u20131799.","DOI":"10.1038\/s41366-020-0598-3"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198806303182602","article-title":"Colchicine in the Treatment of Cirrhosis of the Liver","volume":"318","author":"Kershenobich","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_46","first-page":"281","article-title":"Colchicine Treatment of Liver Fibrosis","volume":"53","author":"Nikolaidis","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mehy.2016.08.006","article-title":"Colchicine to Decrease Inflammation and Fibrosis in Patients with Metabolic Dysregulation","volume":"95","author":"Nikolaidis","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13098-024-01369-x","article-title":"Emerging Insights into the Role of IL-1 Inhibitors and Colchicine for Inflammation Control in Type 2 Diabetes","volume":"16","author":"Guan","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/dc05-2327","article-title":"Diabetes, Hyperglycemia, and Inflammation in Older Individuals","volume":"29","author":"Peila","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A Role for Mitochondria in NLRP3 Inflammasome Activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Chu, C.-C., Chen, Y.-C., Lin, M.-H., Wu, W.-T., Liu, F.-C., Chen, H.-C., Chou, Y.-C., and Sun, C.-A. (2022). Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19063395"},{"key":"ref_52","first-page":"7","article-title":"Colchicine has Antidiabetic Effect and May be an Option for Type 2 Diabetes Management","volume":"10","author":"Younis","year":"2020","journal-title":"J. Pharmacol. Res. Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11886-024-02026-5","article-title":"Update on the Role of Colchicine in Cardiovascular Disease","volume":"26","author":"Banco","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e021198","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"10","author":"Kofler","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10554-024-03046-6","article-title":"High Systemic Inflammation as a Novel Cardiovascular Risk Factor and Target for Anti-Cytokine Therapy: Comment Regarding the Triglyceride Glucose Index","volume":"40","author":"Cabrera","year":"2024","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and Atherosclerosis: A Comprehensive Review of Studies in Mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"104598","DOI":"10.1016\/j.mvr.2023.104598","article-title":"Neutrophil-to-Lymphocyte Ratio an Inflammatory Biomarker, and Prognostic Marker in Heart Failure, Cardiovascular Disease and Chronic Inflammatory Diseases: New Insights for a Potential Predictor of Anti-Cytokine Therapy Responsiveness","volume":"150","author":"Galeote","year":"2023","journal-title":"Microvasc. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease","volume":"82","author":"Nelson","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.amjmed.2021.01.019","article-title":"The Use of Colchicine in Cardiovascular Diseases: A Systematic Review","volume":"134","author":"Siak","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780340806","article-title":"Long-term Colchicine Treatment in Children with Familial Mediterranean Fever","volume":"34","author":"Zemer","year":"1991","journal-title":"Arthritis Rheum."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2020.03.065","article-title":"Colchicine and Leukopenia: Clinical Implications","volume":"224","author":"Sag","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vph.2018.09.004","article-title":"Colchicine Reduces Platelet Aggregation by Modulating Cytoskeleton Rearrangement via Inhibition of Cofilin and LIM Domain Kinase 1","volume":"111","author":"Cimmino","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"ref_65","first-page":"4","article-title":"Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization","volume":"107","author":"Zarpelon","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/rheumatology\/kes211","article-title":"Gout and Its Comorbidities: Implications for Therapy","volume":"52","author":"Stamp","year":"2013","journal-title":"Rheumatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5694\/mja12.10333","article-title":"Myopathy and Possible Intestinal Dysfunction in a Patient Treated with Colchicine and Simvastatin","volume":"197","author":"Oh","year":"2012","journal-title":"Med. J. Aust."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5414\/CN108343","article-title":"Colchicine Toxicity in Renal Patients\u2014Are We Paying Attention?","volume":"86","author":"Medani","year":"2016","journal-title":"Clin. Nephrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-007-0435-1","article-title":"Which Statin Should Be Used Together with Colchicine? Clinical Experience in Three Patients with Nephrotic Syndrome Due to AA Type Amyloidosis","volume":"28","author":"Sahin","year":"2008","journal-title":"Rheumatol. Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/RHU.0b013e318156d977","article-title":"Rapid Onset of Muscle Weakness (Rhabdomyolysis) Associated With the Combined Use of Simvastatin and Colchicine","volume":"13","author":"Justiniano","year":"2007","journal-title":"JCR J. Clin. Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00002826-200209000-00008","article-title":"Colchicine-Induced Acute Myopathy in a Patient With Concomitant Use of Simvastatin","volume":"25","author":"Hsu","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mus.20135","article-title":"Cytoskeletal Myotoxicity from Simvastatin and Colchicine","volume":"30","author":"Baker","year":"2004","journal-title":"Muscle Nerve"},{"key":"ref_73","unstructured":"U.S. National Library of Medicine (2024, August 07). Home-ClinicalTrials.gov. Clinicaltrials.gov, Available online: https:\/\/clinicaltrials.gov."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Jaiswal, V., Deb, N., Hanif, M., Wajid, Z., Nasir, Y.M., Naz, S., Kalra, K., Qaiser, S., Shrestha, A.B., and Bandyopadhyay, D. (2024). Efficacy of Colchicine for Prevention of Stroke and Adverse Cardiovascular Events: A Meta-Analysis of 16 Randomized Controlled Trials. Am. J. Cardiovasc. Drugs.","DOI":"10.1007\/s40256-024-00689-7"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11886-024-02049-y","article-title":"Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation","volume":"26","author":"Zhang","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/M23-2788","article-title":"Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians","volume":"177","author":"Qaseem","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12933-022-01572-y","article-title":"Effectiveness and Safety of GLP-1 Receptor Agonists versus SGLT-2 Inhibitors in Type 2 Diabetes: An Italian Cohort Study","volume":"21","author":"Baviera","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"JC54","DOI":"10.7326\/J24-0026","article-title":"In Patients with Type 2 Diabetes and Recent MI, Colchicine Reduced a Composite CV Outcome at 23 Mo","volume":"177","author":"Bates","year":"2024","journal-title":"Ann. Intern. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2337\/dc23-1825","article-title":"Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"47","author":"Roubille","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e003872","DOI":"10.1136\/rmdopen-2023-003872","article-title":"Safety and Efficacy of Colchicine in Crystal-Induced Arthritis Flare in 54 Patients with Severe Chronic Kidney Disease","volume":"10","author":"Bausson","year":"2024","journal-title":"RMD Open"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.37765\/ajmc.2022.89292","article-title":"A Review of Current Guidelines for the Treatment of Obesity","volume":"28","author":"Cornier","year":"2022","journal-title":"Am. J. Manag. Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000430801","article-title":"2014 EASO Position Statement on the Use of Anti-Obesity Drugs","volume":"8","author":"Toplak","year":"2015","journal-title":"Obes Facts"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCULATIONAHA.108.189702","article-title":"Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science)","volume":"118","author":"Kumanyika","year":"2008","journal-title":"Circulation"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/14\/11\/629\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:39Z","timestamp":1760114019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/14\/11\/629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":83,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["metabo14110629"],"URL":"https:\/\/doi.org\/10.3390\/metabo14110629","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]}}}